Total Valuation
Nanobiotix has a market cap or net worth of €1.77B. The enterprise value is €1.60B.
Market Cap€1.77B
Enterprise Value€1.60B
Share Statistics
Nanobiotix has 50,619,583 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding50,619,583
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Nanobiotix’s return on equity (ROE) is 0.28 and return on invested capital (ROIC) is -74.29%.
Return on Equity (ROE)0.28
Return on Assets (ROA)-0.35
Return on Invested Capital (ROIC)-74.29%
Return on Capital Employed (ROCE)-1.06
Revenue Per Employee305.60K
Profits Per Employee-247.02K
Employee Count97
Asset Turnover0.44
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Nanobiotix is ―. Nanobiotix’s PEG ratio is 0.59.
PE Ratio―
PS Ratio31.19
PB Ratio-10.94
Price to Fair Value-10.94
Price to FCF-27.22
Price to Operating Cash Flow-49.91
PEG Ratio0.59
Income Statement
In the last 12 months, Nanobiotix had revenue of 29.64M and earned -23.96M in profits. Earnings per share was -0.51.
Revenue29.64M
Gross Profit29.64M
Operating Income-10.82M
Pretax Income-23.96M
Net Income-23.96M
EBITDA-12.07M
Earnings Per Share (EPS)-0.51
Cash Flow
In the last 12 months, operating cash flow was -33.42M and capital expenditures -546.00K, giving a free cash flow of -33.97M billion.
Operating Cash Flow-33.42M
Free Cash Flow-33.97M
Free Cash Flow per Share-0.67
Dividends & Yields
Nanobiotix pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.15
52-Week Price Change743.78%
50-Day Moving Average32.38
200-Day Moving Average23.55
Relative Strength Index (RSI)58.74
Average Volume (3m)127.00
Important Dates
Nanobiotix upcoming earnings date is Sep 30, 2026, TBA (Confirmed).
Last Earnings DateMay 20, 2026
Next Earnings DateSep 30, 2026
Ex-Dividend Date―
Financial Position
Nanobiotix as a current ratio of 1.09, with Debt / Equity ratio of -112.83%
Current Ratio1.09
Quick Ratio1.09
Debt to Market Cap0.10
Net Debt to EBITDA-3.53
Interest Coverage Ratio-1.04
Taxes
In the past 12 months, Nanobiotix has paid 3.00K in taxes.
Income Tax3.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Nanobiotix EV to EBITDA ratio is -80.15, with an EV/FCF ratio of -28.47.
EV to Sales32.63
EV to EBITDA-80.15
EV to Free Cash Flow-28.47
EV to Operating Cash Flow-28.94
Balance Sheet
Nanobiotix has €52.75M in cash and marketable securities with €95.32M in debt, giving a net cash position of -€42.57M billion.
Cash & Marketable Securities€52.75M
Total Debt€95.32M
Net Cash-€42.57M
Net Cash Per Share-€0.84
Tangible Book Value Per Share-€1.78
Margins
Gross margin is 100.00%, with operating margin of -36.49%, and net profit margin of -80.83%.
Gross Margin100.00%
Operating Margin-36.49%
Pretax Margin-80.82%
Net Profit Margin-80.83%
EBITDA Margin-40.71%
EBIT Margin-45.75%
Analyst Forecast
The average price target for Nanobiotix is €55.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target€55.00
Price Target Upside97.27% Upside
Analyst ConsensusStrong Buy
Analyst Count3
Revenue Growth Forecast―
EPS Growth Forecast―